MedPath

Effect of Vitamin E Fortified Whey Drink on Nutritional, Inflammatory and Oxidative Markers in Hemodialysis Patients

Phase 2
Completed
Conditions
Chronic Kidney Disease
Interventions
Dietary Supplement: whey drink,
Dietary Supplement: whey drink fortified with vitaminE
Dietary Supplement: vitamin E
Registration Number
NCT02163070
Lead Sponsor
Mohammad Hassan Eftekhari
Brief Summary

The purpose of the study is to evaluate the effect of vitamin E fortified whey drink on nutritional status, inflammatory markers and oxidative stress in hemodialysis patients

Detailed Description

The aim of this interventional study was to evaluate the effect of vitamin E fortified whey drink on nutritional status, inflammatory markers and oxidative stress in hemodialysis patients. 92 hemodialysis patients were selected for the study. Inclusion criteria included: mean age of 17-65 years old; having mild, moderate or severe malnutrition based on the SGA (subjective global assessment) assessment; being dialyzed at least 2 times a week for 3 months. Exclusion criteria included: hospitalization in the last month; active infection; using immunosuppressant drugs or multi-vitamins; pregnancy. The Ethics Committee of Shiraz University of Medical Sciences reviewed and approved the protocol of this study.Informed consent were signed by all of them for participating in the study. Weight and height of the patients were recorded for BMI (body mass index) calculation. Then, all of the patients were assigned into 4 groups:

1. consumption of 220 milliliters of whey drink three times a week,

2. consumption of 220 milliliters of whey drink fortified with 400 milligrams of vitamin E three times a week,

3. consumption of 400 milligrams of vitamin E three times a week,

4. control group: no intervention. Patients were followed for 2 months. At the beginning and the end of the 2-month intervention period, 10 milliliters of blood were taken from all of the patients and nutritional status of the patients were assessed as the primary outcome. Serum levels of malondialdehyde, c-reactive protein, albumin, transferrin and lipoproteins were also measured. SGA, MIS and SF-12 questionnaires were filled for all of the patients at the beginning and the end of the study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
92
Inclusion Criteria
  • mean age of 17-65 years old;
  • having mild, moderate or severe malnutrition based on the SGA (subjective global assessment) assessment;
  • be dialyzed at least 2 times a week for 3 months
Exclusion Criteria
  • hospitalization in the last month;
  • active infection;
  • using immunosuppressant drugs or multi-vitamins;
  • pregnancy, consuming whey or soy products

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
whey drinkwhey drink,consumption of 220 milliliters of whey drink three times a week,
whey drink fortified with vitaminEwhey drink fortified with vitaminEconsumption of 220 milliliters of whey drink fortified with 400 milligrams of vitamin E three times a week,
vitaminEvitamin Econsumption of 400 milligrams of vitamin E three times a week,
Primary Outcome Measures
NameTimeMethod
malnutrition (based on SGA assessment)2 months (8 weeks)
Malnutrition inflammation score2 months (8 weeks)
Secondary Outcome Measures
NameTimeMethod
serum calcium2 months (8 weeks)
serum interleukin-62 months (8 weeks)
serum C-reactive protein2 months (8 weeks)
serum albumin2 months (8 weeks)
serum creatinine2 months (8 weeks)
serum phosphate2 months (8 weeks)
quality of life2 months (8 weeks)
Body mass index2 months (8 weeks)
serum transferrin2 months (8 weeks)
weight2 months (8 weeks)
serum HDL-c2 months (8 weeks)
serum total cholesterol2 months (8 weeks)
serum triglyceride2 months (8 weeks)
height2 months (8 week)
serum malondialdehyde2 months (8 weeks)
BUN (blood urea nitrogen)2 months (8 weeks)
© Copyright 2025. All Rights Reserved by MedPath